We are live on ! Find out more
NVIV

InVivo Therapeutics Holdings Corp
NVIV

Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

13 hedge funds and large institutions have $258K invested in InVivo Therapeutics Holdings Corp in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

19% less funds holding

Funds holding: 16 → 13 (-3)

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

62% less capital invested

Capital invested by funds: $673K → $258K (-$415K)

Holders
13
Holders Change
-3
Holders Change %
-18.75%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
2
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$79.4K
2
TRCT
Tower Research Capital (TRC)
New York
+$2.62K
3
Morgan Stanley
Morgan Stanley
New York
+$16
4
Osaic Holdings
Osaic Holdings
Arizona
+$16
5
IA
IFP Advisors
Florida
+$11

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$101K
2
State Street
State Street
Massachusetts
-$76K
3
Renaissance Technologies
Renaissance Technologies
New York
-$27K
4
Northern Trust
Northern Trust
Illinois
-$24K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$14K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$141K -$11 -2 -0%
Citadel Advisors
2
Citadel Advisors
Florida
$62K +$79.4K +15,127 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$44K +$5 +1 +0%
Morgan Stanley
4
Morgan Stanley
New York
$5K +$16 +3 +0.3%
TRCT
5
Tower Research Capital (TRC)
New York
$4K +$2.62K +498 +125%
IA
6
IFP Advisors
Florida
$2K +$11 +2 New
Vanguard Group
7
Vanguard Group
Pennsylvania
– -$101K -11,704 Closed
State Street
8
State Street
Massachusetts
– -$76K -8,795 Closed
Renaissance Technologies
9
Renaissance Technologies
New York
– -$27K -3,172 Closed
Northern Trust
10
Northern Trust
Illinois
– -$24K -2,821 Closed
Two Sigma Advisers
11
Two Sigma Advisers
New York
– -$14K -1,568 Closed
UBS Group
12
UBS Group
Switzerland
– -$5.28K -1,006 -100%
ICM
13
IMS Capital Management
Oregon
– -$7K -806 Closed
Millennium Management
14
Millennium Management
New York
– -$4K -461 Closed
Citigroup
15
Citigroup
New York
– -$1K -116 Closed
Bank of America
16
Bank of America
North Carolina
– +$5 +1 New
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
– +$5 +1 +1%
SWM
18
Sugarloaf Wealth Management
Georgia
– +$5 +1 New
Wells Fargo
19
Wells Fargo
California
– +$5 +1 +13%
TF
20
TimeScale Financial
Massachusetts
– +$11 +2 New
Osaic Holdings
21
Osaic Holdings
Arizona
– +$16 +3 +75%

NVIV Hedge Fund Activity: Q2 2022 in Review

13 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q2 2022, worth a combined $258K — down 62% from $673K a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of NVIV and 5 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 6 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $79.4K. The largest seller was Vanguard Group, exiting entirely with an estimated $101K sold.

  • 13 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q2 2022, down from 16 in Q1 2022.
  • Funds reported $258K of InVivo Therapeutics Holdings Corp stock for Q2 2022, down 62% quarter-over-quarter.
  • 5 funds opened new InVivo Therapeutics Holdings Corp positions in Q2 2022 and 8 closed out, a net change of -3 holders.
  • The largest InVivo Therapeutics Holdings Corp buyer in Q2 2022 was Citadel Advisors, an estimated $79.4K added.
  • The largest InVivo Therapeutics Holdings Corp seller in Q2 2022 was Vanguard Group, an estimated $101K sold.

Based on aggregated 13F filings for Q2 2022.